ATHE Neutral Sentiment Score: 55/100
ASX ANNOUNCEMENT 19 July 2024 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under se
Friday, July 19, 2024 1 min read
Key Takeaway: Alterity Therapeutics Limited announced the issuance of 75,220,800 fully paid ordinary shares as part of their compliance with Section 708A(5)(e) of the Corporations Act. The shares were issued on July 18, 2024. This notice serves to inform stakeholders under the legal requirements of the Corporations Act 2001 (Cth). The announcement reflects procedural compliance rather than a significant event affecting the company's strategic direction.
Full Press Release Details
Notice Under Section 708A(5)(e)
This notice is given by Alterity
Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e)
of the Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
| Type | Shares |
| Class/Description | Fully paid ordinary shares |
| ASX Code | ATH |
| Date of Issue | 18 July 2024 |
| Number Issued | 75, 220,800 |
The Company gives notice pursuant to
section 708A(5)(e) of the Corporations Act that:
Alterity Therapeutics Limited ACN 080 699 065
Level 3, 62 Lygon Street Carlton Victoria